104 related articles for article (PubMed ID: 3017457)
1. Amplification and rearrangement of Ki-ras oncogene in human teratocarcinoma-derived cell lines.
Tobaly-Tapiero J; Saal F; Peries J; Emanoil-Ravier R
Biochimie; 1986; 68(7-8):1019-23. PubMed ID: 3017457
[TBL] [Abstract][Full Text] [Related]
2. Studies on four cellular proto-oncogenes and their expression in PCC4 embryonal carcinoma cells: amplification of c-Ki-ras oncogene.
Vilette D; Emanoil-Ravier R; Tobaly J; Peries J
Biochem Biophys Res Commun; 1985 Apr; 128(2):513-9. PubMed ID: 2986619
[TBL] [Abstract][Full Text] [Related]
3. Cellular oncogenes in human teratocarcinoma cell lines.
Tesch H; Fürbass R; Casper J; Lyons J; Bartram CR; Schmoll HJ; Bronson DL
Int J Androl; 1990 Oct; 13(5):377-88. PubMed ID: 2283183
[TBL] [Abstract][Full Text] [Related]
4. c-Ki-ras gene amplification and malignant behavior in murine embryonal carcinoma cell lines.
Vilette D; Emanoil-Ravier R; Buffe D; Rimbaut C; Peries J
Cancer Res; 1987 Feb; 47(3):867-73. PubMed ID: 3542196
[TBL] [Abstract][Full Text] [Related]
5. Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes.
Yamada H; Sakamoto H; Taira M; Nishimura S; Shimosato Y; Terada M; Sugimura T
Jpn J Cancer Res; 1986 Apr; 77(4):370-5. PubMed ID: 3009377
[TBL] [Abstract][Full Text] [Related]
6. Oncogene alterations in in vitro transformed rat tracheal epithelial cells.
Mass MJ; Schorschinsky NS; Lasley JA; Beeman DK; Austin SJ
Mutat Res; 1990 Apr; 243(4):291-8. PubMed ID: 1691445
[TBL] [Abstract][Full Text] [Related]
7. Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas.
Smith DM; Groff DE; Pokul RK; Bear JL; Delgado G
Am J Obstet Gynecol; 1989 Oct; 161(4):911-5. PubMed ID: 2801838
[TBL] [Abstract][Full Text] [Related]
8. Sublocalization of c-myb to 6q21----q23 by in situ hybridization and c-myb expression in a human teratocarcinoma with 6q rearrangements.
Janssen JW; Vernole P; de Boer PA; Oosterhuis JW; Collard JG
Cytogenet Cell Genet; 1986; 41(3):129-35. PubMed ID: 3007038
[TBL] [Abstract][Full Text] [Related]
9. Amplification and enhanced expression of the c-Ki-ras2 protooncogene in human embryonal carcinomas.
Wang LC; Vass W; Gao CL; Chang KS
Cancer Res; 1987 Aug; 47(15):4192-8. PubMed ID: 2886216
[TBL] [Abstract][Full Text] [Related]
10. Expression of cellular oncogenes in teratoma-derived cell lines.
Sejersen T; Sümegi J; Ringertz NR
Exp Cell Res; 1985 Sep; 160(1):19-30. PubMed ID: 2412863
[TBL] [Abstract][Full Text] [Related]
11. Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation.
Dmitrovsky E; Murty VV; Moy D; Miller WH; Nanus D; Albino AP; Samaniego F; Bosl G; Chaganti RS
Oncogene; 1990 Apr; 5(4):543-8. PubMed ID: 2183156
[TBL] [Abstract][Full Text] [Related]
12. Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours.
Fujita J; Yoshida O; Yuasa Y; Rhim JS; Hatanaka M; Aaronson SA
Nature; 1984 May 31-Jun 6; 309(5967):464-6. PubMed ID: 6328318
[TBL] [Abstract][Full Text] [Related]
13. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
[TBL] [Abstract][Full Text] [Related]
14. A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells.
Schwab M; Alitalo K; Varmus HE; Bishop JM; George D
Nature; 1983 Jun 9-15; 303(5917):497-501. PubMed ID: 6304530
[TBL] [Abstract][Full Text] [Related]
15. Causal role for an activated N-ras oncogene in the induction of tumorigenicity acquired by a human cell line.
Tainsky MA; Shamanski F; Blair D; Giovanella BC
Cancer Res; 1987 Jun; 47(12):3235-8. PubMed ID: 3034405
[TBL] [Abstract][Full Text] [Related]
16. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
[TBL] [Abstract][Full Text] [Related]
17. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
Kiefer PE; Bepler G; Kubasch M; Havemann K
Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
[TBL] [Abstract][Full Text] [Related]
18. Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood.
Rodenhuis S; Bos JL; Slater RM; Behrendt H; van 't Veer M; Smets LA
Blood; 1986 Jun; 67(6):1698-704. PubMed ID: 3011151
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
20. Expression of N-myc in teratocarcinoma stem cells and mouse embryos.
Jakobovits A; Schwab M; Bishop JM; Martin GR
Nature; 1985 Nov 14-20; 318(6042):188-91. PubMed ID: 3840574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
